Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Income from Continuing Operations (2016 - 2025)

Assembly Biosciences (ASMB) has 11 years of Income from Continuing Operations data on record, last reported at 9196000.0 in Q3 2025.

  • For Q3 2025, Income from Continuing Operations rose 4.34% year-over-year to 9196000.0; the TTM value through Sep 2025 reached 38547000.0, up 5.53%, while the annual FY2024 figure was 40177000.0, 34.38% up from the prior year.
  • Income from Continuing Operations reached 9196000.0 in Q3 2025 per ASMB's latest filing, up from 10198000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 8818000.0 in Q1 2025 and bottomed at 62788000.0 in Q4 2021.
  • Average Income from Continuing Operations over 5 years is 18689210.53, with a median of 16896000.0 recorded in 2023.
  • Peak YoY movement for Income from Continuing Operations: plummeted 461.45% in 2021, then surged 64.33% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 62788000.0 in 2021, then soared by 64.33% to 22395000.0 in 2022, then skyrocketed by 51.05% to 10962000.0 in 2023, then rose by 5.72% to 10335000.0 in 2024, then grew by 11.02% to 9196000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 9196000.0 in Q3 2025, 10198000.0 in Q2 2025, and 8818000.0 in Q1 2025.